Acceptable ODM Surgical Instrument Laparoscopy Trocar Reusable Multifunctional Valve 5.5mm

4 Company Show

FAQ

Advantages of minimally invasive surgery for brain tumors Health education

Minimally invasive surgery for brain tumors has many advantages. The following is a detailed health education content:

Small wounds and few scars: The incisions of minimally invasive surgery are usually very small, about 0.5 to 1 cm, and basically no scars are left, which is an important advantage for patients who pay attention to appearance.

Light pain and fast recovery: Due to the small trauma, the postoperative pain is less and the patient recovers faster. This not only reduces the patient's pain, but also shortens the hospital stay.

Less bleeding: Minimally invasive surgery causes less bleeding during the operation, which helps reduce postoperative complications and speed up recovery.

Accurate positioning: Modern neurosurgical technology, such as minimally invasive surgery guided by neuronavigation robots, can achieve more accurate positioning and tumor removal, reducing damage to surrounding normal tissues.

Advanced technology: Minimally invasive surgery requires high-end medical equipment and technical support. Although the cost of surgery is high, its high precision and safety make the surgery more effective and less risky.

Wide range of indications: Minimally invasive surgery is suitable for the treatment of a variety of brain tumors, including complex cases such as secondary trigeminal neuralgia caused by cholesteatoma compression and tuberculum sellae meningioma.

High quality of life after surgery: Minimally invasive surgery has a high quality of life for patients after surgery due to its small trauma and fast recovery, and they can return to daily life and work faster.

Multidisciplinary collaboration: Minimally invasive surgery often requires the cooperation of a multidisciplinary team, combining expertise in multiple fields such as neurosurgery, imaging, and pathology to develop individualized treatment plans to ensure the success rate and safety of the operation.

In short, minimally invasive surgery has significant advantages in the treatment of brain tumors, including small trauma, fast recovery, and few complications, and is an important direction for the development of modern medicine. Patients should fully understand these advantages when undergoing minimally invasive surgery and work closely with doctors to obtain the best treatment results.

What are the latest technological advances in minimally invasive surgery for brain tumors?

The latest technological advances in minimally invasive surgery for brain tumors mainly include the following aspects:

Robot-assisted stereotactic biopsy and intraoperative rapid molecular pathology combined diagnosis: The Department of Neurosurgery of Qilu Hospital of Shandong University has carried out the first intraoperative MRI-guided laser interstitial thermal therapy (MRgLITT) for gliomas guided by robot-assisted stereotactic biopsy and intraoperative rapid molecular pathology combined diagnosis in China, which marks the entry of minimally invasive surgery for brain tumors into the era of intelligent and precise diagnosis and treatment.

Laser interstitial thermal therapy (LITT): Laser interstitial thermal therapy is a minimally invasive surgical technique introduced in recent years. Its main advantages lie in its minimal invasiveness and wide applicability. It can be applied to areas that are difficult to handle with microsurgery. In addition, new technologies combining imaging stereotactic navigation and microcatheter laser thermal therapy are also developing. Lasers are applied to target tumor lesions in the brain through optical fibers, thereby selectively ablating the diseased tissue.

Neuroendoscopic surgery: Neuroendoscopic technology has been increasingly used for the resection and biopsy of brain parenchymal tumors, with the advantages of less trauma and faster recovery. For example, the neurosurgery department of Shijingshan Hospital successfully carried out neuroendoscopic transnasal-sphenoidal pituitary tumor resection, and the patient recovered well after the operation without any complications.

Micro-device implantation: Researchers have designed a new device the size of a grain of rice, which is implanted into brain tumors through minimally invasive surgery, providing unprecedented insights into the effects of drugs on brain gliomas, thereby helping to study the effects of new therapies on refractory brain tumors.

How effective and safe is minimally invasive surgery in treating specific types of brain tumors (such as glioblastoma and solid tumors)?

Minimally invasive surgery has significant advantages in the effectiveness and safety of treating specific types of brain tumors (such as glioblastoma and solid tumors).

For glioblastoma, minimally invasive surgery can maximize the removal of the tumor while protecting the surrounding normal brain tissue. Studies have shown that maximum surgical resection helps increase the patient's likelihood of long-term survival. In addition, some brain tumors that cannot be safely removed surgically can be treated with laser interstitial thermal therapy (LITT), a minimally invasive surgical method that uses heat to destroy brain tumors from the inside out. Despite this, the recurrence rate of glioblastoma is still high. Once recurred, there is a lack of effective treatment and the prognosis is poor.

For multi-site solid tumors, minimally invasive surgical treatment has been widely used and has achieved good results. Through precise diagnosis, precise treatment and individualized follow-up plans, minimally invasive surgery has significantly prolonged the patient's survival. Radiofrequency ablation is also a common minimally invasive surgical method, which has small trauma, fast postoperative recovery, little effect on the body's immune function, and can reduce the risk of tumor spread.

In short, minimally invasive surgery has significant effects and high safety in the treatment of specific types of brain tumors. It can maximize the removal of tumors, reduce damage to surrounding normal tissues, and help improve the patient's quality of life and survival.

What is the cost-effectiveness comparison between minimally invasive surgery and traditional laparotomy in the treatment of brain tumors?

The cost-effectiveness comparison between minimally invasive surgery and traditional laparotomy in the treatment of brain tumors is as follows:

Cost range:

The cost of minimally invasive brain surgery is roughly between 50,000 yuan and 200,000 yuan. The specific cost will vary depending on the patient's condition, the complexity of the operation, and the hospital.

Surgical effect and recovery time:

Minimally invasive surgery has the advantages of small surgical incision, few complications, short operation time and fast recovery. For example, Monteris' minimally invasive surgery can ablate the entire brain tumor through multiple trajectories for lesions with a diameter greater than or equal to 3cm, with a scalp incision of less than 4mm and skull drilling and puncture.
In addition, minimally invasive surgery in difficult intracranial locations under neuroendoscopy not only improves the tumor resection rate, but also gives tumor patients a better prognosis.

Cost-effectiveness analysis:

Minimally invasive neurosurgery (MIS) can improve health outcomes and reduce medical costs in patients with spontaneous supratentorial intracerebral hemorrhage (ICH).
By analyzing the clinical data and economic data of 735 patients with spontaneous intracerebral hemorrhage treated with minimally invasive surgery in four tertiary-level A hospitals in Beijing, Shanghai, Hangzhou and Suzhou from 2018 to 2021, it was found that minimally invasive surgery performed well in cost-effectiveness evaluation.
Minimally invasive surgery has a lower risk of complications, faster recovery time and higher cost-effectiveness in the treatment of brain tumors, especially in the treatment of certain specific types of brain tumors, such as minimally invasive surgery for spontaneous cerebral hemorrhage and complex brain tumors.

What are the studies on the long-term survival rate and quality of life of patients after minimally invasive surgery?

There are several important studies on the long-term survival rate and quality of life of patients after minimally invasive surgery:

Cervical cancer surgery: According to a study published in the New England Journal of Medicine, cervical cancer patients who choose minimally invasive surgery have lower disease-free survival and overall survival rates than open surgery, while the cancer recurrence rate is higher than the latter.

Lung cancer surgery: A study compared the effects of open chest surgery, traditional laparoscopic minimally invasive surgery and "tubeless" surgery on the long-term survival of lung cancer patients. The results showed that "tubeless" surgery can significantly improve the patient's survival rate 5 years after surgery.

Robotic surgery versus traditional minimally invasive surgery: A systematic review and meta-analysis found that the global quality of life after robotic surgery was significantly better than that of traditional minimally invasive surgery, especially after prostatectomy and gastrectomy.

Quality of life after cervical cancer surgery: Secondary results of a multicenter, randomized, open-label, phase 3, non-inferiority trial showed that the quality of life scores of open and minimally invasive (laparoscopic) cervical cancer surgery were similar at 6 weeks or 3 months after surgery, with no statistical difference.

Esophageal cancer surgery: Studies have shown that there is controversy over the long-term survival rate of minimally invasive esophagectomy (MIE) compared with open esophagectomy (OE). Some studies have shown that the long-term survival rate of MIE may be inferior to that of OE, but some studies have pointed out that there is no significant difference between the two.

Gallstone surgery: A study showed that minimally invasive cholelithotomy (EMIC) has a better quality of life after surgery than laparoscopic cholecystectomy (LC).

What are the latest studies or cases of minimally invasive surgery in preventing recurrence and reducing recurrence strategies?

There are many latest studies and cases of minimally invasive surgery in preventing recurrence and reducing recurrence. Here are some specific examples:

Cervical cancer: Professor Ramirez's research shows that the risk of recurrence in open surgery is three times that of minimally invasive surgery, which means that open surgery may be more suitable for the treatment of early cervical cancer.

Inguinal incarcerated hernia: Zheng Huiming's research shows that laparoscopic minimally invasive surgery can improve the patient's recovery speed, reduce postoperative pain, reduce complications and recurrence rate, thereby improving the patient's quality of life.

Kidney stones: By constructing a minimally invasive recurrence risk model for kidney stones, the factors affecting recurrence related to health behaviors were analyzed, and evidence-based strategies were provided for clinical nursing intervention.

Lumbar disc herniation: Using specially designed intervertebral foraminal endoscopes and corresponding minimally invasive spinal surgical instruments, the lumbar annulus fiber is heated to restore it to its normal state, thereby reducing the recurrence rate.

Internal hemorrhoids: Zhu Ying's research shows that patients with internal hemorrhoids who have preoperative clinical symptoms more than 3 months after surgery need to undergo endoscopic sclerosing, band ligation, and ligation and sclerosing combined treatment again to evaluate the recurrence rate.

Tumor boundary elimination: Yang Jian's team determines the key to the success of minimally invasive tumor surgery by evaluating the effect of tumor boundary elimination, which helps to control and reduce the postoperative recurrence rate.

Colorectal liver metastasis: Studies have shown that for patients with resectable CRLM after conversion therapy, preoperative DEB-TACE treatment is a safe option to prolong recurrence-free survival. It makes full use of microspheres as drug carriers and embolic agents to make drug release more stable and effective.

Nasopharyngeal carcinoma: New minimally invasive surgical treatment increases the 5-year survival rate of recurrent nasopharyngeal carcinoma by 20-30%, improves the quality of life score by about 1 times, and reduces medical expenses by about 4/5.

For more photos and details please contact me:
Company Name: Tonglu Wanhe Medical Instruments Co., Ltd.
Sales: Sue